Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "cough"

63 News Found

Control Print’s 3-ply surgical masks receive USFDA 510(K) authorisation
News | January 25, 2022

Control Print’s 3-ply surgical masks receive USFDA 510(K) authorisation

The company has been manufacturing masks since the Covid-19 outbreak in 2020


Experts highlight positives of yoga in coping with Covid waves
Public Health | January 19, 2022

Experts highlight positives of yoga in coping with Covid waves

Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run


Indian pharma industry registers 5.3% YoY revenue growth in Dec 2021 : Ind-Ra
News | January 12, 2022

Indian pharma industry registers 5.3% YoY revenue growth in Dec 2021 : Ind-Ra

Ind-Ra expects revenue growth of over 12% in 2022.


A 39-year-old patient with Covid-19 was saved with ECMO support
Hospitals | December 22, 2021

A 39-year-old patient with Covid-19 was saved with ECMO support

Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital


Amrutanjan Health Care opens first store in Chennai
News | December 02, 2021

Amrutanjan Health Care opens first store in Chennai

The offline store launch will complement the E-commerce website in building a rich consumer shopping experience


Masimo Rad-G helps identify paediatric pneumonia in India
Medical Device | November 29, 2021

Masimo Rad-G helps identify paediatric pneumonia in India

Rad-G is a rugged, portable, handheld Masimo SET Measure-through Motion and Low Perfusion pulse oximeter and noninvasive respiration rate monitor


Wadia Hospital, Mumbai introduces tests for cystic fibrosis
Hospitals | November 15, 2021

Wadia Hospital, Mumbai introduces tests for cystic fibrosis

This test is inexpensive and results are available immediately as compared to the genetic test


U.S. FDA expands approval of Dupixent to include children aged 6 to 11 years
Drug Approval | October 22, 2021

U.S. FDA expands approval of Dupixent to include children aged 6 to 11 years

Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option


Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment
News | September 15, 2021

Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment

These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients


Delfi liquid biopsy shows promise for reducing lung cancer deaths
Biotech | August 23, 2021

Delfi liquid biopsy shows promise for reducing lung cancer deaths

When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers